341 related articles for article (PubMed ID: 15698433)
1. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
Xu ZG; Yoo TH; Ryu DR; Cheon Park H; Ha SK; Han DS; Adler SG; Natarajan R; Kang SW
Kidney Int; 2005 Mar; 67(3):944-52. PubMed ID: 15698433
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone-related protein induces hypertrophy in podocytes via TGF-beta(1) and p27(Kip1): implications for diabetic nephropathy.
Romero M; Ortega A; Izquierdo A; López-Luna P; Bosch RJ
Nephrol Dial Transplant; 2010 Aug; 25(8):2447-57. PubMed ID: 20200004
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytes.
Lee EY; Shim MS; Kim MJ; Hong SY; Shin YG; Chung CH
Exp Mol Med; 2004 Feb; 36(1):65-70. PubMed ID: 15031673
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli.
Xu ZG; Miao LN; Cui YC; Jia Y; Yuan H; Wu M
Nephrol Dial Transplant; 2009 Jun; 24(6):1744-52. PubMed ID: 19103735
[TBL] [Abstract][Full Text] [Related]
5. P-Cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies.
Xu ZG; Ryu DR; Yoo TH; Jung DS; Kim JJ; Kim HJ; Choi HY; Kim JS; Adler SG; Natarajan R; Han DS; Kang SW
Nephrol Dial Transplant; 2005 Mar; 20(3):524-31. PubMed ID: 15647309
[TBL] [Abstract][Full Text] [Related]
6. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
[TBL] [Abstract][Full Text] [Related]
7. The effects of angiotensin-II receptor blockers on podocyte damage and glomerular apoptosis in a rat model of experimental streptozotocin-induced diabetic nephropathy.
Tunçdemir M; Oztürk M
Acta Histochem; 2011 Dec; 113(8):826-32. PubMed ID: 21269661
[TBL] [Abstract][Full Text] [Related]
8. Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli.
Xu HZ; Wang WN; Zhang YY; Cheng YL; Xu ZG
J Nephrol; 2016 Dec; 29(6):775-782. PubMed ID: 27021232
[TBL] [Abstract][Full Text] [Related]
9. ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy.
Gross ML; El-Shakmak A; Szábó A; Koch A; Kuhlmann A; Münter K; Ritz E; Amann K
Diabetologia; 2003 Jun; 46(6):856-68. PubMed ID: 12802493
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes.
Rüster C; Bondeva T; Franke S; Förster M; Wolf G
Nephrol Dial Transplant; 2008 Jul; 23(7):2179-91. PubMed ID: 18344241
[TBL] [Abstract][Full Text] [Related]
11. Local delivery of angiotensin II receptor blockers into the kidney passively attenuates inflammatory reactions during the early phases of streptozotocin-induced diabetic nephropathy through inhibition of calpain activity.
Kamal F; Yanakieva-Georgieva N; Piao H; Morioka T; Oite T
Nephron Exp Nephrol; 2010; 115(3):e69-79. PubMed ID: 20424485
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis occurs differentially according to glomerular size in diabetic kidney disease.
Jung DS; Lee SH; Kwak SJ; Li JJ; Kim DH; Nam BY; Kang HY; Chang TI; Park JT; Han SH; Yoo TH; Kang SW
Nephrol Dial Transplant; 2012 Jan; 27(1):259-66. PubMed ID: 21652547
[TBL] [Abstract][Full Text] [Related]
13. Glomerular expression of p27Kip1 in diabetic db/db mouse: role of hyperglycemia.
Wolf G; Schroeder R; Thaiss F; Ziyadeh FN; Helmchen U; Stahl RA
Kidney Int; 1998 Apr; 53(4):869-79. PubMed ID: 9551393
[TBL] [Abstract][Full Text] [Related]
14. Activation of the renin-angiotensin system within podocytes in diabetes.
Yoo TH; Li JJ; Kim JJ; Jung DS; Kwak SJ; Ryu DR; Choi HY; Kim JS; Kim HJ; Han SH; Lee JE; Han DS; Kang SW
Kidney Int; 2007 May; 71(10):1019-27. PubMed ID: 17361112
[TBL] [Abstract][Full Text] [Related]
15. Podocyte hypertrophy precedes apoptosis under experimental diabetic conditions.
Lee SH; Moon SJ; Paeng J; Kang HY; Nam BY; Kim S; Kim CH; Lee MJ; Oh HJ; Park JT; Han SH; Yoo TH; Kang SW
Apoptosis; 2015 Aug; 20(8):1056-71. PubMed ID: 25953318
[TBL] [Abstract][Full Text] [Related]
16. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
[TBL] [Abstract][Full Text] [Related]
17. Roles of 12-Lipoxygenase and Its Interaction with Angiotensin II on p21 and p27 Expression in Diabetic Nephropathy.
Zhang YY; Wang WN; Su SS; Chen B; Sun WX; Wu H; Cheng YL; Xu ZG
Nephron; 2019; 142(1):61-70. PubMed ID: 30677774
[TBL] [Abstract][Full Text] [Related]
18. Inducible nitric oxide synthase (iNOS) expression is increased in lipopolysaccharide (LPS)-stimulated diabetic rat glomeruli: effect of ACE inhibitor and angiotensin II receptor blocker.
Lee HY; Noh HJ; Gang JG; Xu ZG; Jeong HJ; Kang SW; Choi KH; Han DS
Yonsei Med J; 2002 Apr; 43(2):183-92. PubMed ID: 11971212
[TBL] [Abstract][Full Text] [Related]
19. FR167653 inhibits fibronectin expression and apoptosis in diabetic glomeruli and in high-glucose-stimulated mesangial cells.
Jung DS; Li JJ; Kwak SJ; Lee SH; Park J; Song YS; Yoo TH; Han SH; Lee JE; Kim DK; Moon SJ; Kim YS; Han DS; Kang SW
Am J Physiol Renal Physiol; 2008 Aug; 295(2):F595-604. PubMed ID: 18524857
[TBL] [Abstract][Full Text] [Related]
20. Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms.
Okada T; Wada J; Hida K; Eguchi J; Hashimoto I; Baba M; Yasuhara A; Shikata K; Makino H
Diabetes; 2006 Jun; 55(6):1666-77. PubMed ID: 16731829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
